Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies

Background: Around 30% Parkinson's disease (PD) patients develop impulse control disorders (ICDs) to D(2/3) dopamine agonists and, to a lesser extent, levodopa. We aim to investigate striatal dopaminergic function in PD patients with and without ICD. Methods: PubMed, Science Direct, EBSCO, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Alice, Dal Lago, Denise, Edelstyn, Nicola M. J., Salgarello, Matteo, Lugoboni, Fabio, Tamburin, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290338/
https://www.ncbi.nlm.nih.gov/pubmed/30568628
http://dx.doi.org/10.3389/fneur.2018.01018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290338/
https://www.ncbi.nlm.nih.gov/pubmed/30568628
http://dx.doi.org/10.3389/fneur.2018.01018

Ejemplares similares